Skip to main content
SpringerLink
Log in

Sepsis and septic shock

II. Treatment

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Mortality from septic shock is considerable despite the advantages of cardiovascular support and antibiotic therapy. This article reviews current therapy of septic shock including immunotherapy and futher possibilities of septic shock treatment. The role of cytokines, their inhibitors and antibodies to endotoxin is mentioned. Although these treatments hold much promise for the future, careful evalution of both the benefits and complications of therapy is needed before widespread clinical use can be recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andus T, Leser H-G, Gross V, Scholmerich J (1991) Akutphase-Proteine: Regulation der Synthese durch Entzündungsmediatoren und klinische Bedeutung. Intensivmedizin 28:2–10

    Google Scholar 

  2. Bakker J, Coffernils M, Leon M, et al (1991) Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 99:956–962

    Google Scholar 

  3. Barandun S, Imbach P, Kindt H, et al (1982) Clinical applications of immunoglobulin. Sandoz, Basle, p 88

    Google Scholar 

  4. Bauer J, Herrmann F (1991) Interleukin-6 in clinical medicine. Ann Hematol 62:203–210

    Google Scholar 

  5. Baumann H, Gauldie J (1990) Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7:147–159

    Google Scholar 

  6. Baumgartner J-D (1992) Anti-endotoxin therapy in the management of sepsis. J Antimicrob Chemother 29:360–362

    Google Scholar 

  7. Baumgartner J-D, McCuthan JA, Van Melle G, et al (1985) Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet II:59–63

    Google Scholar 

  8. Bekes CE, Bayly RW, Dellinger RP, et al (1992) Guidelines for the care of patients with hemodynamic instability associated with sepsis. Crit Care Med 20:1057–1059

    Google Scholar 

  9. Benjamin E, Liebowitz AB, Oropello J, Iberti TS (1992) Systemic hypoxic and inflammatory syndrome: an alternative designation for sepsis syndrome. Crit Care Med 20:680–682

    Google Scholar 

  10. Berkman SA, Lee ML, Gale RP (1990) Clinical uses of intravenous immunoglobulins. Ann Intern Med 112:278–292

    Google Scholar 

  11. Bernat A, Herbert JM, Salel V, et al (1992) Protective effect of SR 27417, a novel PAF antagonist, on PAF- or endotoxin-induced hypotension in the rat and the guinea-pig. J Lipid Mediators 5:41–48

    Google Scholar 

  12. Bodey GP (1993) Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis 17 [Suppl 2]: 378–384

    Google Scholar 

  13. Bodey GP, Rodriguez V, Chang H-Y, Narboni G (1978) Fever and infection in leukemic patient. A study of 494 consecutive cases. Cancer 41:1610–1622

    Google Scholar 

  14. Bodey GP, Bolivar R, Fainstein V (1982) Infectious complications in leukemic patients. Semin Hematol 19:193–226

    Google Scholar 

  15. Bollaert PE, Bauer P, Audibert G, et al (1990) Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 98:949–953

    Google Scholar 

  16. Bone RC (1991) Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med 114:332–333

    Google Scholar 

  17. Bone RC (1991) Let's agree on terminology: definitions of sepsis. Crit Care Med 19:973–976

    Google Scholar 

  18. Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115:457–469

    Google Scholar 

  19. Bone RC (1991) A critical evaluation of new agents for treatment of sepsis. JAMA 266:1686–1691

    Google Scholar 

  20. Bone RC (1992) Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med 152:1381–1389

    Google Scholar 

  21. Bone RC (1992) Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452–3455

    Google Scholar 

  22. Bone RC, Fisher C, Clemmer TP (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658

    Google Scholar 

  23. Bone RC, Sibbald WJ, Sprung CL (1992) The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481–1482

    Google Scholar 

  24. Bone RC, Balk RA, Cerra FB, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655

    Google Scholar 

  25. Bone RC, Balk RA, Cerra FB, et al (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874

    Google Scholar 

  26. Briegel J, Forst H, Hellinger H, Haller M (1991) Contribution of cortisol deficiency to septic shock. Lancet 338:507–508

    Google Scholar 

  27. Buckley RH, Schiff RI (1991) The use of intravenous immunoglobulin in immunodeficiency disease. N Engl J Med 325:110–115

    Google Scholar 

  28. Calandra T, Glauser MP, Schellekens J, et al (1988) Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5. J Infect Dis 158:312–319

    Google Scholar 

  29. Calandra T, Gerain J, Heumann D, et al (1991) High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 91:23–30

    Google Scholar 

  30. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771–778

    Google Scholar 

  31. Cavallion J-M, Munoz C, Fitting C, et al (1992) Circulating cytokines: the tip of the iceberg? Circ Shock 38:145–152

    Google Scholar 

  32. Chang H-Y, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ (1976) Causes of death in adults with acute leukemia. Medicine 55:259–268

    Google Scholar 

  33. Clemmer TP, Fisher CJ, Bone RC, et al (1992) Hypothermia in the sepsis syndrome and clinical outcome. Crit Care Med 20:1395–1401

    Google Scholar 

  34. Clevenger FW (1993) Nutritional support in the patient with the systemic inflammatory response syndrome. Am J Surg 165 [Suppl 2A]: 68–74

    Google Scholar 

  35. Cohen I L (1993) Definitions for sepsis and organ failure. The ACCP/SCCM Consensus Conference Committee report. Chest 103:656

    Google Scholar 

  36. Cohn J, Bone RC (1992) New strategies in nonantibiotic treatment of gram-negative sepsis. Cleve Clin J Med 59:608–615

    Google Scholar 

  37. Cohen J, Exley AR (1993) Treatment of septic shock with antibodies to tumour necrosis factor. Schweiz Med Wochenschr 123:492–496

    Google Scholar 

  38. Colardyn FC, Vandenbogaerde JF, Vogelaers DP, et al (1989) Use of dopexamin hydrochloride in patients with septic shock. Crit Care Med 17:999–1003

    Google Scholar 

  39. Corriveau CC, Danner RL (1993) Antiendotoxin therapies for septic shock. Infect Agents Dis 2:44–52

    Google Scholar 

  40. Crespo MS, Fernandez-Gallardo S (1991) Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock. J Lipid Mediators 4:127–144

    Google Scholar 

  41. Cross AS, Opal SM, Palardy JE, et al (1993) The efficacy of combination immunotherapy in experimental Pseudomonas sepsis. J Infect Dis 167:112–118

    Google Scholar 

  42. Cunnion RE (1990) Myocardial depressant substance. Ann Intern Med 113:237–239

    Google Scholar 

  43. Damas P, Reuter A, Gysen P, et al (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975–978

    Google Scholar 

  44. Danner RL (1990) Mediators and endotoxin inhibitors. Ann Intern Med 113:235–237

    Google Scholar 

  45. Dantzker DR (1993) Adequacy of tissue oxygenation. Crit Care Med 21 [Suppl 2]:S40-S43

    Google Scholar 

  46. De Boer JP, Wolbink GJ, Thijs LG, et al (1992) Interplay of complement and cytokines in the pathogenesis of septic shock. Immunopharmacology 24:135–148

    Google Scholar 

  47. Dhainaut JF, Edwards JD, Grootendorst AF, et al (1990) Practical aspects of oxygen transport: conclusions and recommendations of the roundtable conference. Intensive Care Med 16 [Suppl 2]:179–180

    Google Scholar 

  48. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627–1652

    Google Scholar 

  49. Dinarello CA, Cannon JG (1993) Cytokine measurements in septic shock. Ann Intern Med 119:853–854

    Google Scholar 

  50. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328:106–113

    Google Scholar 

  51. Dofferhoff ASM (1991) The role of cytokines in septic shock and speculations on future therapies. Neth J Med 39:1–5

    Google Scholar 

  52. Dofferhoff ASM, Vellenga E, Limburg PC, et al (1991) Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature. Neth J Med 38:46–63

    Google Scholar 

  53. Dofferhoff ASM, De Jong DJ, Bom VJJ, et al (1992) Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis 24:197–204

    Google Scholar 

  54. Dominioni L, Dionigi R, Zanello M (1991) Effect of high-dose IgG on survival of surgical patients with sepsis score of 20 or greater. Arch Surg 126:236–240

    Google Scholar 

  55. Duke GJ, Bersten AD (1992) Dopamine and renal salvage in the critically ill patient. Anaesth Intensive Care 20:277–302

    Google Scholar 

  56. Emerson TE Jr, Lindsey DC, Jesmok GJ, et al (1992) Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model. Circ Shock 38:75–84

    Google Scholar 

  57. Endo S, Inada K, Inoue Y, et al (1992) Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ Shock 38:264–274

    Google Scholar 

  58. Estey EH, Keating MJ, McCredie KM, Bodey GP, Freireich EJ (1982) Causes of initial remission induction failure in acute myelogenous leukemia. Blood 60:309–315

    Google Scholar 

  59. Exley AR, Cohen J, Buurman W, et al (1992) Monoclonal antibody to TNF in severe septic shock. Lancet 335:1275–1277

    Google Scholar 

  60. Fiedler VB, Loof I, Sander E, et al (1992) Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys. J Lab Clin Med 120:574–588

    Google Scholar 

  61. Fink MP (1993) Adoptive immunotherapy of gram-negative sepsis use of monoclonal antibodies to lipopolysaccharide. Crit Care Med 21: S32-S39

    Google Scholar 

  62. Fischer JE, Hasselgren P-O (1991) Cytokines and glucocorticoids in the regulation of the “hepato-skeletal muscle axis” in sepsis. Am J Surg 161:266–271

    Google Scholar 

  63. Fisher CJ Jr, Opal SM, Dhainaut J-F, et al (1993) Influence of an antitumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 21:318–327

    Google Scholar 

  64. Fisher CJ, Slotman GJ, Opal SM, et al (1994) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open labeled, placebo controlled multicenter trial. Crit Care Med 22:12–21

    Google Scholar 

  65. Fletcher JR (1991) Ibuprofen in patients with severe sepsis. Crit Care Med 19:1331–1332

    Google Scholar 

  66. Fourrier F, Chopin C, Goudemand J, et al (1991) Septic shock, multiple organ failure and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 101:816–823

    Google Scholar 

  67. Fudenberg HH, Fudenberg HH (1989) Transfer factor: past, present and future. Ann Rev Pharmacol Toxicol 29:475–516

    Google Scholar 

  68. Goris RJA (1990) Mediators of multiple organ failure. Intensive Care Med 16 [Suppl 3]:191–196

    Google Scholar 

  69. Greenman RL, Schein RMH, Martin MA, et al (1991) A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 266:1097–1102

    Google Scholar 

  70. Gregory JS, Bonfiglio MF, Dasta JF, et al (1991) Experience with phenylephrine as component of the pharmacologic support of septic shock. Crit Care Med 19:1395–1400

    Google Scholar 

  71. Groeneveld ABJ (1990) Septic shock and multiple organ failure treatment with hemofiltration? Intensive Care Med 16:489–490

    Google Scholar 

  72. Hack CE, De Groot ER, Felt-Bersma RJF, et al (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704–1710

    Google Scholar 

  73. Hack CE, Hart M, Strack RJM, et al (1992) Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60:350–358

    Google Scholar 

  74. Hackshaw KV, Parker GA, Roberts JW (1990) Naloxone in septic shock. Crit Care Med 18:47–51

    Google Scholar 

  75. Hanique G, Dugernier T, Laterre PF, et al (1994) Significance of pathologic oxygen supply dependency in critically ill patients: comparison between measured and calculated methods. Intensive Care Med 20:12–18

    Google Scholar 

  76. Harbour DV, Galin FS, Hughes TK, et al (1991) Role of leukocyte-derived pro-opiomelanocortin peptides in endotoxic shock. Circ Shock 35:181–191

    Google Scholar 

  77. Haupt MT, Jastremski MS, Clemmer TP, et al (1991) Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. Crit Care Med 19:1339–1347

    Google Scholar 

  78. Hoffkens HG, Ehrlly AM (1992) Optimal hematocrit in patients with intermittent claudications. Exercise induced muscle tissue oxygen pressure after stepwise isovolemic hemodilution. Clin Hemorheol 12 [Suppl 1]:41–55

    Google Scholar 

  79. Hotchkiss RS, Karl IE (1992) Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 267:1503–1510

    Google Scholar 

  80. Jesmok G, Lindsey C, Duerr M, et al (1992) Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine. Am J Pathol 141:1197–1207

    Google Scholar 

  81. John RCS, Dorinsky PM (1993) Immunologic therapy for ARDS, septic shock and multiple-organ failure. Chest 103:932–943

    Google Scholar 

  82. Klastersky J (1993) Empirical antibiotic therapy in neutropenic cancer patients. Eur J Cancer 22A [Suppl 1]: S6-S10

    Google Scholar 

  83. Kreimeier U, Ruiz-Moralez M, Messmer K (1993) Comparsion of the effects of volume resuscitation with dextran 60 vs Ringer's lactate on central hemodynamics, regional blood flow, pulmonary function, and blood composition during hyperdynamic endotoxemia. Circ Shock 39:89–99

    Google Scholar 

  84. Lanser K, Balikcioglu S (1988) Continuous intravenous infusion of immunoglobulin M in septic shock. In: Deicher H, Schoeppe W (eds) Klinisch angewandte Immunologie. Springer, Berlin Heidelberg New York, pp 42–49

    Google Scholar 

  85. Leach RM, Treacher DF (1992) Oxygen transport: the relation between oxygen delivery and consumption. Thorax 47:971–978

    Google Scholar 

  86. Levi M, Cate H ten, Poll T van der, et al (1993) Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270:975–979

    Google Scholar 

  87. Levine AS, Schimpff SC, Graw RG, Young RC (1974) Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol 11:141–202

    Google Scholar 

  88. Marchant A, Deviere J, Byl B, et al (1994) Interleukin-10 production during septicaemia. Lancet 343:707–708

    Google Scholar 

  89. Marks JD, Marks CB, Luce JM, et al (1990) Plasma tumor necrosis factor in patients ith septic shock. Am Rev Respir Dis 141:94–97

    Google Scholar 

  90. Martich GD, Boujoukos AJ, Suffredini AF (1993) Response of man to endotoxin. Immunobiol 197:403–416

    Google Scholar 

  91. Martin C, Papazian L, Perrin G, et al (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 103:1826–1831

    Google Scholar 

  92. Maynard N, Bihari D, Beale R, et al (1993) Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 270:1203–1210

    Google Scholar 

  93. McClelland P, Williams PS, Yaqoob M, et al (1990) Multiple organ failure — a role for plasma exchange? Intensive Care Med 16:100–103

    Google Scholar 

  94. McManus ML, Churchwell KB (1993) Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura. Crit Care Med 21:706–711

    Google Scholar 

  95. Mileski WJ (1991) Sepsis. What it is and how to recognize it. Surg Clin North Am 71:749–764

    Google Scholar 

  96. Mitsuo T, Shimazaki S, Matsuda H (1992) Right ventricular dysfunction in septic patients. Crit Care Med 20:630–634

    Google Scholar 

  97. Molooy RG, Mannick JA, Rodrick ML (1993) Cytokines, sepsis and immunomodulation. Br J Surg 80:289–297

    Google Scholar 

  98. Moran JL, O'Fathartaigh MS, Peisach AR, et al (1993) Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 21:70–77

    Google Scholar 

  99. Morrison HM, Doepfner P, Park GR (1991) Vasopressin in septic shock — a useful of dangerous agent? Intensive Care Med 17:243–243

    Google Scholar 

  100. Munoz C, Misset B, Fitting C, et al (1991) Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol 21:2177–2184

    Google Scholar 

  101. Nasraway SA, Rackow EC, Astiz ME, et al (1989) Inotropic response to digoxin and dopamine in patients with severe sepsis, cardiac failure and systemic hypoperfusion. Chest 95:612–617

    Google Scholar 

  102. Natanson C (1990) A canine model of septic shock. Ann Intern Med 113:231–233

    Google Scholar 

  103. Nydegger UE (1992) Intravenous immunoglobulin in combination with other prophylactic and therapeutic measures. Transfusion 32:72–82

    Google Scholar 

  104. Ognibene FP (1990) Management of septic shock. Ann Intern Med 113:239–240

    Google Scholar 

  105. Packman MI, Rackow EC (1983) Optimal left heart filling pressure during fluid resuscitation of patients with hypovolemia and septic shock. Crit Care Med 11:165–169

    Google Scholar 

  106. Parker MM (1990) Cardiac dysfunction in human septic shock. Ann Intern Med 113:229–231

    Google Scholar 

  107. Parrillo JE (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227–242

    Google Scholar 

  108. Parrillo JE (1993) Pathogenetic mechanism of septic shock. N Engl J Med 328:1471–1477

    Google Scholar 

  109. Perret C (1992) Sepsis: la confusion des termes. Schweiz Med Wochenschr 122:758–761

    Google Scholar 

  110. Pilz G, Kaab S, Neeser G, et al (1991) Supplemental immunoglobulin treatment in 163 patients with sepsis and septic shock. Infection 19:216–227

    Google Scholar 

  111. Pilz G, Fateh-Moghadam S, Viell B, et al (1993) Supplemental immunoglobulin therapy in sepsis and septic shock — comparison of mortality under treatment with polyvalent i.v. immunoglobulin versus placebo. Protocol of a multicenter, randomized, prospective, double-blind trial. Theor Surg 8:61–83

    Google Scholar 

  112. Pinsky MR, Vincent J-L, Deviere J, et al (1993) Serum cytokine levels in human septic shock. Relation to multiple-organ failure and mortality. Chest 103:565–575

    Google Scholar 

  113. Pizzo PA (1993) Management of fever in patients with cancer and treatment — induced neutropenia. N Engl J Med 328:1323–1332

    Google Scholar 

  114. Pollack M (1992) Editorial response: blood exchange and plasmapheresis in sepsis and septic shock. Clin Infect Dis 15:431–433

    Google Scholar 

  115. Preiser JC, Schmartz D, Van der Linden P, et al (1991) Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog. Cytokine 3:1–4

    Google Scholar 

  116. Quezado ZMN, Natanson C, Alling DW, et al (1993) A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA 269:2221–2227

    Google Scholar 

  117. Rackow EC, Astiz ME (1991) Pathophysiology and treatment of septic shock. JAMA 266:548–554

    Google Scholar 

  118. Reinhart K, Hannemann L, Kuss B (1990) Optimal oxygen delivery in critically ill patients. Intensive Care Med 16 [Suppl 2]:149–155

    Google Scholar 

  119. Roman J, Fernandez F, Velasco F, et al (1993) Serum TNF levels in neonatal sepsis and septic schock. Acta Paediatr 82:352–354

    Google Scholar 

  120. Ronco JJ, Fenwick JC, Tweeddale MG, et al (1993) Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic human. JAMA 270:1724–1730

    Google Scholar 

  121. Schaer GL, Fink MP, Parrillo JE (1985) Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 13:492–496

    Google Scholar 

  122. Schedel I, Dreikhausen U, Nentwig B, et al (1991) Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit Care Med 19:1104–1113

    Google Scholar 

  123. Schimpff SC (1993) Gram-negative bacteremia. Support Care Cancer 1:5–8

    Google Scholar 

  124. Schneider AJ, Voerman HJ (1991) Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids. Intensive Care Med 17:436–437

    Google Scholar 

  125. Schulman KA, Glick HA, Rubin H, Eisengerg JM (1991) Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of new therapeutic agent. JAMA 266:3466–3471

    Google Scholar 

  126. Shibutani K, Komatsu T, Kubal K, et al (1983) Critical level of oxygen delivery in anesthetized man. Crit Care Med 11:640–645

    Google Scholar 

  127. Sjolin J (1991) High dose corticosteroids therapy in human septic shock: has the jury reached a correct verdict? Circ Shock 35:139–451

    Google Scholar 

  128. Smithies M, Bihari DJ (1993) Delivery dependent oxygen consumption: asking the wrong questions and not getting any answers. Crit Care Med 1993:1622–1626

    Google Scholar 

  129. Snell RJ, Parrillo JE (1991) Cardiovascular dysfunction in septic shock. Chest 99:1000–1009

    Google Scholar 

  130. Sprung CL (1991) Definitions of sepsis — have we reached a consensus? Crit Care Med 19:849–851

    Google Scholar 

  131. Sprung CL, Caralis PV, Marcial EH (1984) The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 311:1137–1143

    Google Scholar 

  132. Stanford GG (1991) Use of inotropic agents in critical illness. Surg Clin North Am 71:683–698

    Google Scholar 

  133. Steinmetz HT, Bertram M, Riediger A, et al (1993) Pattern of cytokines in leucopenic fever (abstract). Ann Hematol 67: A122

  134. Suffredini AF (1990) Endotoxin administration to normal humans. Ann Intern Med 113:233–235

    Google Scholar 

  135. Takala J, Ruokonen E (1992) Oxygen transport in septic shock. Schweiz Med Wochenschr 122:776–779

    Google Scholar 

  136. Taylor FB Jr, Chang A, Ruf W, et al (1991) Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 33:127–134

    Google Scholar 

  137. The Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect of high dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659–665

    Google Scholar 

  138. Todd AAM, Yap PL (1992) Applications of intravenous immunoglobulin in haematology. Blood Rev 6:105–117

    Google Scholar 

  139. Tompkins RG (1994) Human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome. Crit Care Med 22:3

    Google Scholar 

  140. Tracey KJ (1991) Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ Shock 35:123–128

    Google Scholar 

  141. Tuschschmidt J, Fried J, Swinney R, Sharma OP (1989) Early hemodynamic correlates of survival in patients with septic shock. Crit Care Med 17:719–723

    Google Scholar 

  142. Tuchschmidt J, Oblitas D, Fried C (1991) Oxygen consumption in sepsis and septic shock. Crit Care Med 19:664–671

    Google Scholar 

  143. Van der Meer Jos WM (1988) Defects in host-defense mechanisms. In: Rubin R H, Young LS (eds) Clinical approach to infection in the compromised host. Plenum Press, New York, p 685

    Google Scholar 

  144. Van der Poll T, Sauerwein HP (1993) Tumor necrosis factor alpha: its role in the metabolic response to sepsis. Clin Sci 84:247–256

    Google Scholar 

  145. Van Zee KJ, DeForge LE, Fischer E, et al (1991) IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 146:3478–3482

    Google Scholar 

  146. Villard J, Roux-Lombard P, Hugli A, et al (1993) Could natural inhibitors of tumor necrosis factor alpha modify the clinical course of fulminant meningococcemia? Crit Care Med 21:1396–1400

    Google Scholar 

  147. Vincent J-L (1991) Advances in the concepts of intensive care. Am Heart J 121:1859–1865

    Google Scholar 

  148. Vincent J-L (1993) Oxygen transport in severe sepsis. Acta Anaesthesiol Scand 37 [Suppl 98]:29–31

    Google Scholar 

  149. Vincent J-L (1994) Renal effects of dopamine: can our dream ever come true? Crit Care Med 22:5–6

    Google Scholar 

  150. Vincent J-L, Bihari D (1992) Sepsis, severe sepsis or sepsis syndrome: need for clarifications. Intensive Care Med 18:255–257

    Google Scholar 

  151. Vincent J-L, Boelpaepe C, Luypaert P, et al (1988) Association of amrinone with norepinephrine in endotoxic shock in dogs (abstract). Crit Care Med 16:402

    Google Scholar 

  152. Vincent J-L, Gris P, Coffernils M, et al (1992) Myocardial depression characterizes the fatal course of septic shock. Surgery 111:660–667

    Google Scholar 

  153. Vincent J-L, Bakker J, Marcecaux G, et al (1992) Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Chest 101:810–815

    Google Scholar 

  154. Vogel F (1988) Assessment of intravenous IgM therapy in severe nosocomial infections: results of a controlled randomized study. In: Deicher H, Schoeppe W (eds) Klinisch angewandte Immunologie. Springer, Berlin Heidelberg New York, pp 30–41

    Google Scholar 

  155. Wade JC, Schimpff SC (1988) Epidemiology and prevention of infection in the compromised host. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host. Plenum Press, New York, p 685

    Google Scholar 

  156. Warren HS, Danner RL, Munford RS (1992) Anti-endotoxin monoclonal antibodies. N Engl J Med 326:1153–1157

    Google Scholar 

  157. Wenzel RP (1992) Anti-endotoxin monoclonal antibodies — a second look. N Engl J Med 326:1151–1153

    Google Scholar 

  158. Wilson W, Lipman J, Scribante J, et al (1992) Septic shock: does adrenalin have a role as a first-line agent? Anaesth Intensive Care 20:470–474

    Google Scholar 

  159. Wortel CH, Mohlen AM von der, Deventer SJH van, et al (1992) Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in a gram-negative sepsis. J Infect Dis 166:1367–1374

    Google Scholar 

  160. Yoshikawa D, Gotto F (1992) Effect of platelet-activating factor antagonist and leukotriene antagonist on endotoxin shock in the rat: role of the leukocyte. Circ Shock 38:29–33

    Google Scholar 

  161. Ziegler EJ, McCuthan A, Fierer J, et al (1982) Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307:1225–1230

    Google Scholar 

  162. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324:429–436

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Masaryk University Hospital, Brno Bohunice, Jihlavska 20, 63900, Brno, Czech Republic

    Jiri Mayer M.D., Roman Hajek M.D., Jiri Vorlicek M.D. & Miroslav Tomiska M.D.

Authors
  1. Jiri Mayer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roman Hajek M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiri Vorlicek M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miroslav Tomiska M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mayer, J., Hajek, R., Vorlicek, J. et al. Sepsis and septic shock. Support Care Cancer 3, 111–119 (1995). https://doi.org/10.1007/BF00365850

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00365850

Key words

Search

Navigation